Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TADALAFIL 5MG TABLET Resolved 2024-03-28 2024-04-25 223859
TEVA-TELMISARTAN 80MG TABLET Resolved 2024-01-11 2024-04-25 215728
TEVA-TELMISARTAN 40MG TABLET Resolved 2023-07-20 2024-04-25 199393
TEVA-FLUVASTATIN 20MG CAPSULE Resolved 2023-11-03 2024-04-25 209111
TEVA-BETAHISTINE 24MG TABLET Resolved 2024-02-01 2024-04-25 218129
TEVA-OLANZAPINE 5MG TABLET Resolved 2024-03-28 2024-04-25 223844
TEVA-SERTRALINE 100MG CAPSULE Resolved 2024-03-21 2024-04-25 222938
TEVA-NAPROXEN 500MG TABLET Resolved 2024-02-01 2024-04-25 218123
TEVA-CEPHALEXIN 250 250MG POWDER FOR SUSPENSION Resolved 2023-08-03 2024-04-25 200864
ACT DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-01-25 2024-04-25 217240
ACT DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-02-01 2024-04-25 218145
TEVA-TADALAFIL 2.5MG TABLET Actual shortage 2024-04-25 2024-04-25 226177
TEVA-BUSPIRONE 10MG TABLET Actual shortage 2024-04-25 2024-04-25 226174
TEVA-ECTOSONE 0.1% LOTION Actual shortage 2024-04-25 2024-04-25 226171
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Actual shortage 2024-01-11 2024-04-25 215760
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-01-11 2024-04-25 215751
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2024-03-07 2024-04-25 221534
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-04-25 223862
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-05 2024-04-25 224445
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-07 2024-04-25 221546

Showing 1 to 20 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-OLMESARTAN / HCTZ 40MG 12.5MG TABLET Discontinued 2020-06-11 2020-06-11 117516
TEVA-OLMESARTAN / HCTZ 20MG 12.5MG TABLET Discontinued 2020-06-11 2020-06-11 117513
TEVA-OLMESARTAN 40MG TABLET Discontinued 2020-06-11 2020-06-11 117500
TEVA-OLMESARTAN 20MG TABLET Discontinued 2020-06-11 2020-06-11 117497
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117494
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117491
ACT DILTIAZEM T 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115126
ACT DILTIAZEM T 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115123
ACT DILTIAZEM T 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115120
ACT DILTIAZEM T 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115117
ACT DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115114
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2020-05-14 2020-05-14 115088
TEVA-ARIPIPRAZOLE 2MG TABLET Discontinued 2020-05-14 2020-05-14 115085
ACT RANITIDINE 300MG TABLET Discontinued 2020-05-14 2020-05-14 115082
ACT RANITIDINE 150MG TABLET Discontinued 2020-05-14 2020-05-14 115079
TEVA-PAROXETINE 30MG TABLET Discontinued 2020-02-21 2020-02-21 106901
TEVA-PAROXETINE 10MG TABLET Discontinued 2020-02-21 2020-02-21 106898
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173

Showing 61 to 80 of 250